Biocair, an established global leader in life science logistics, celebrates significant milestones achieved throughout 2025, marking a year of strategic international expansion, sustainability progress and continued investment in digital innovation to further expand global partnerships and customer support.
Biocair has advanced its long-term growth strategy with major developments across its international network, including expansion into the APAC market with a new office in Chengdu and a new state-of-the-art APAC Control Tower HQ in Shanghai. Additionally, Biocair opened a new facility in Paris, enhancing capacity for temperature-controlled storage and distribution across Europe through its strategic positioning within the Paris-Charles de Gaulle airport cargo zone, and further strengthened its operational footprint in India, where the company is experiencing strong, sustained growth.
"Biocair’s growth this year underscores our commitment to developing the infrastructure, expertise and global reach needed to meet – and exceed – the evolving needs of the life sciences community. These expansions enable us to deliver even greater value to our customers as the life science sector accelerates and supply chains become more complex."
— Vincent Howard, Chief Executive Officer, Biocair
Biocair continued to reach its sustainability goals throughout 2025, reinforced by a strong performance in the EcoVadis Corporate Social Responsibility assessment. The company achieved an advanced rating, placing Biocair within the top 13% of companies globally in its sector. These achievements reflect Biocair’s ongoing investment in responsible operations and align with the company’s Roadmap to Net Zero by 2040, which continues to guide strategic decision-making across facilities, fleet and customer solutions. Customer adoption of Biocair Connect, the company’s shipment management platform, increased substantially in 2025. Throughout the year, customers praised the system’s simplicity, responsiveness and seamless integration into their workflows. Biocair also reinforced its commitment to digital security, achieving Cyber Essentials Plus Accreditation, further strengthening protection for customer data and digital operations.
Despite a dynamic regulatory landscape, including challenges such as shifting US tariff structures, Biocair’s specialist teams continued to provide expert customs guidance for life science shipments. Biocair Customs Brokerage experts supported customers in navigating changing requirements to ensure compliant and uninterrupted product movement across borders.
Additionally, Biocair maintained a strong presence at key life science logistics and advanced therapies events worldwide, sharing insights and strengthening partnerships. These appearances demonstrate Biocair’s commitment not only to supporting customers, but to shaping the future of global life science logistics alongside leading industry experts.
After a successful 2025, Biocair enters 2026 poised for further expansion, continued digital transformation and deeper strategic partnerships.
"As we look toward 2026, we remain focused on strengthening relationships, expanding our global presence and investing in the innovation required to support our vision of delivering products that improve and save lives. We are excited for the growth ahead and grateful to our customers, partners and teams for their continued trust and collaboration."
— Vincent Howard, Chief Executive Officer, Biocair
